PKM2 and cancer: The function of PKM2 beyond glycolysis
G Dong, Q Mao, W Xia, Y Xu, J Wang… - Oncology …, 2016 - spandidos-publications.com
Metabolic reprogramming is a hallmark of cancer cells and is used by cancer cells for growth
and survival. Pyruvate kinase muscle isozyme M2 (PKM2) is a limiting glycolytic enzyme that …
and survival. Pyruvate kinase muscle isozyme M2 (PKM2) is a limiting glycolytic enzyme that …
Digging deeper through glucose metabolism and its regulators in cancer and metastasis
M Ghanavat, M Shahrouzian, ZD Zayeri… - Life sciences, 2021 - Elsevier
Glucose metabolism enzymes and transporters play major role in cancer development and
metastasis. In this study, we discuss glucose metabolism, transporters, receptors, hormones …
metastasis. In this study, we discuss glucose metabolism, transporters, receptors, hormones …
Pyruvate kinase M2 at a glance
W Yang, Z Lu - Journal of cell science, 2015 - journals.biologists.com
Reprogrammed metabolism is a key feature of cancer cells. The pyruvate kinase M2 (PKM2)
isoform, which is commonly upregulated in many human cancers, has been recently shown …
isoform, which is commonly upregulated in many human cancers, has been recently shown …
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition
FA Siddiqui, G Prakasam, S Chattopadhyay… - Scientific reports, 2018 - nature.com
Warburg effect is an emerging hallmark of cancer cells with pyruvate kinase M2 (PKM2) as
its key regulator. Curcumin is an extensively-studied anti-cancer compound, however, its …
its key regulator. Curcumin is an extensively-studied anti-cancer compound, however, its …
[HTML][HTML] Pyruvate kinase M2 and cancer: an updated assessment
Cancer cells are characterized by high glycolytic rates to support energy regeneration and
anabolic metabolism, along with the expression of pyruvate kinase isoenzyme M2 (PKM2) …
anabolic metabolism, along with the expression of pyruvate kinase isoenzyme M2 (PKM2) …
The multifaceted regulation and functions of PKM2 in tumor progression
Z Li, P Yang, Z Li - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2014 - Elsevier
Tumor cells undergo metabolic rewiring from oxidative phosphorylation towards aerobic
glycolysis to maintain the increased anabolic requirements for cell proliferation. It is widely …
glycolysis to maintain the increased anabolic requirements for cell proliferation. It is widely …
The role of PKM2 in metabolic reprogramming: insights into the regulatory roles of non-coding RNAs
DL Puckett, M Alquraishi, W Chowanadisai… - International Journal of …, 2021 - mdpi.com
Pyruvate kinase is a key regulator in glycolysis through the conversion of
phosphoenolpyruvate (PEP) into pyruvate. Pyruvate kinase exists in various isoforms that …
phosphoenolpyruvate (PEP) into pyruvate. Pyruvate kinase exists in various isoforms that …
[HTML][HTML] Aspectos bioquímicos y factores de riesgo asociados con el cáncer cervicouterino
J Villafuerte Reinante, Y Hernández Guerra… - Revista Finlay, 2019 - scielo.sld.cu
El cáncer de cuello uterino se encuentra dentro de las principales causas de muerte en la
mujer, por lo que representa un serio problema de salud. Se ha demostrado, mediante …
mujer, por lo que representa un serio problema de salud. Se ha demostrado, mediante …
Structural insight into mechanisms for dynamic regulation of PKM2
Pyruvate kinase isoform M2 (PKM2) converts phosphoenolpyruvate (PEP) to pyruvate and
plays an important role in cancer metabolism. Here, we show that post-translational …
plays an important role in cancer metabolism. Here, we show that post-translational …
Silibinin induces metabolic crisis in triple‐negative breast cancer cells by modulating EGFR‐MYC‐TXNIP axis: potential therapeutic implications
MA Iqbal, S Chattopadhyay, FA Siddiqui… - The FEBS …, 2021 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is an aggressive form of breast cancer with limited
treatment modalities and poor prognosis. Metabolic reprogramming in cancer is considered …
treatment modalities and poor prognosis. Metabolic reprogramming in cancer is considered …